O ‐GlcNAc Transferase Promotes Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Hepatocellular Carcinoma by Facilitating the Degradation of PTEN

Documenti analoghi

• Alcohol Dehydrogenase 4‐Mediated Retinol Metabolism Inhibits Hepatocellular Carcinoma Progression Through Inhibiting the Wnt/β‐Catenin Pathway
  di: Jiaying Li, et al.
  Pubblicazione: (2025)
• X‐Linked Inhibitor of Apoptosis Protein (XIAP) Contributes to ERK1/2‐Mediated Anoikis Resistance in Hepatocellular Carcinoma
  di: Qingyu Zeng, et al.
  Pubblicazione: (2026)
• Activation of Adenosine Phosphate Signaling Promotes Antitumor Immunity in Tumor Microenvironment and Facilitate Immunotherapy
  di: Yantao Xu, et al.
  Pubblicazione: (2025)
• Adjuvant Therapy Combining Donafenib and Sintilimab Enhances Recurrence‐Free Survival in Hepatocellular Carcinoma Patients With High‐Risk Recurrence Factors After Radical Resection: A Retrospective Cohort Study
  di: Hanchuan Shen, et al.
  Pubblicazione: (2025)
• Alcohol‐Related Liver Disease and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Molecular Pathogenesis and Therapeutic Interventions
  di: Yupin Tan, et al.
  Pubblicazione: (2025)